Univ of Montreal
Dept of Biochem
Biographical Sketch: Dr. Michel Bouvier is a world renowned expert and a leading figure in Molecular Pharmacology and Drug discovery. He is an expert in the field of G protein-coupled receptors (GPCR) and made seminal contributions to our understanding of this major class of drug targets. He currently serves as the President and CEO of IRICoR. Professor of Biochemistry at the Université de Montréal since 1989, he is a member of the Executive of the Réseau Québécois de Recherche sur le Médicament. He is a member of many Scientific and Business Advisory Boards for large biopharmaceutical & Biotech.
He played a central role in establishing IRIC’s research programs for drug discovery. He was Chairman of the Biochemistry Department at the Université de Montréal from 1997 to 2005 and the Director of the Groupe de Recherche Universitaire sur les Médicaments from 2005 to 2012. Dr Bouvier holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology. Principal Investigator at the Institute for Research in Immunology and Cancer, he is the author of over 200 scientific papers and delivered more than 300 scientific conferences. More than 39 graduate students and 30 post-doctoral fellows obtained training in his laboratory. His contributions to the field of Molecular Pharmacology were recognized by the attribution of many awards and distinctions including the Hans Selye Chair of Cell Biology, the Merck-Frosst Award from Canadian Society of Biochemistry and Molecular & Cell Biology, the Michel Sarazin Award from the Clinical Research Club of Quebec, and the Senior Investigator Award for outstanding achievement in research from the Canadian Society for Molecular Biosciences. He is a fellow of the Canadian Academy of Health Sciences.
Dr Bouvier holds a B.Sc. in Biochemistry (1979) and a Ph.D. in Neurological Sciences (1985) from Université de Montréal and a post-doctoral fellowship (1985-89) at Duke University.
Conformational Diseases Resulting from GPCR Misfolding and Mis-trafficking Mutations
Symposium 1: Consequences of Structural Variation in GPCRs and their Ligands on Receptor Function
Molecular Basis and Cellular Outcome of GPCR Functional Selectivity and Ligand-Biased Signaling under the Light of Bioluminescence Resonance Energy Transfer (BRET)